Pharmaceutical and biotech facilities have zero tolerance for unplanned power interruptions. Clean rooms, cold storage, bioreactors, and production lines all depend on continuous, reliable power. FDA GMP requirements under 21 CFR 211 mandate that facilities maintain environmental controls — and emergency power is the backbone of those controls during utility outages.
We audit pharmaceutical emergency power systems against NFPA 110 requirements and FDA GMP expectations, identify documentation gaps that could surface during FDA inspections, and build compliance programs that protect both production continuity and regulatory standing.
Why Pharmaceutical Facilities Face Power Compliance Risk
FDA inspections increasingly examine facility infrastructure alongside manufacturing processes. A power interruption that compromises environmental controls can trigger a 483 observation — and a 483 tied to emergency power raises questions about the facility's entire GMP program. The regulatory exposure extends beyond the power event itself to the adequacy of the facility's preventive maintenance and contingency planning.
Insurance underwriters for pharmaceutical facilities also scrutinize emergency power compliance. Business interruption coverage, product liability, and property insurance all factor in the reliability of backup power systems and the documentation that proves maintenance compliance.
Applicable Standards & Regulations
The Cold Storage Failure That Triggered an FDA 483
A pharmaceutical distribution facility experienced a 45-minute utility outage. The emergency generator started and transferred power — but the ATS prioritization left cold storage units on a delayed transfer circuit. Internal temperatures exceeded USP limits for 22 minutes. Three temperature-sensitive product lots had to be quarantined pending stability testing.
Result: FDA inspection three months later identified the incident in the facility's deviation log. The 483 observation cited inadequate emergency power planning for temperature-controlled storage. The facility had to demonstrate corrective action including ATS circuit reprioritization, validated transfer testing, and updated SOPs. Total cost including product quarantine, stability testing, and remediation exceeded $1.2M.
The generator worked. The ATS transferred. But the power distribution prioritization had never been validated against the facility's actual environmental control requirements. A structured compliance audit would have identified the circuit prioritization gap before it became a product quality event.
How We Prepare Your Facility
We audit your facility against the specific standards that apply to your operation, identify the exact gaps that would generate findings, and build the documentation program that proves compliance at every inspection cycle.
- 01Complete review of emergency power infrastructure — generator testing records, ATS transfer verification, UPS system documentation, and power distribution circuit prioritization.
- 02Environmental control validation — verify emergency power transfer times against clean room recovery, cold storage temperature limits, and critical process requirements.
- 03GMP documentation review — cross-reference emergency power records against FDA 21 CFR 211 requirements, deviation logs, and CAPA documentation.
- 04Insurance and business continuity alignment — verify emergency power documentation meets carrier requirements for business interruption and product liability coverage.
- 01Circuit prioritization validation — ensure ATS load shedding and transfer priorities align with actual facility environmental control requirements.
- 02Documentation remediation — build NFPA 110 compliant testing logs, written maintenance program, and GMP-aligned emergency power SOPs.
- 03Vendor coordination — schedule overdue testing with certified vendors and document results to NFPA 110 Chapter 8 standards.
- 01Establish integrated compliance monitoring — align NFPA 110 testing schedules with GMP preventive maintenance programs to eliminate duplicate efforts.
- 02FDA inspection readiness — maintain organized emergency power documentation that can be produced during FDA inspections alongside GMP records.